These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24425711)

  • 21. Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing.
    Zhou Y; Yao X; Liu G; Jian W; Yip W
    BMC Health Serv Res; 2019 Jan; 19(1):43. PubMed ID: 30658628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can preventive therapy alter the initial presentation of coronary heart disease?
    Smith SC
    Ann Intern Med; 2006 Feb; 144(4):296-7. PubMed ID: 16490916
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessing the Quality of Care for Patients With Acute Myocardial Infarction in China.
    Wang Y; Fu R; Wang Z; Bao H; Chen Y; Yang F; Luo X; Liu M
    Clin Cardiol; 2015 Jun; 38(6):327-32. PubMed ID: 26074496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times.
    Saab FA; Eagle KA; Kline-Rogers E; Fang J; Otten R; Mukherjee D;
    Am J Cardiol; 2004 Nov; 94(9):1166-8. PubMed ID: 15518612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary prevention for patients following a myocardial infarction: summary of NICE guidance.
    Skinner JS; Cooper A; Feder GS;
    Heart; 2007 Jul; 93(7):862-4. PubMed ID: 17569811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.
    Guirguis-Blake J
    Am Fam Physician; 2012 Jul; 86(1):21-3. PubMed ID: 22962909
    [No Abstract]   [Full Text] [Related]  

  • 28. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
    Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pravastatin and coronary heart disease.
    Bloom JM
    N Engl J Med; 1999 Apr; 340(14):1116-7. PubMed ID: 10206831
    [No Abstract]   [Full Text] [Related]  

  • 30. Dangers of skipping medications after a heart attack.
    Harv Heart Lett; 2008 May; 18(9):7. PubMed ID: 18655307
    [No Abstract]   [Full Text] [Related]  

  • 31. Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study.
    Gitt AK; Schiele R; Wienbergen H; Zeymer U; Schneider S; Gottwik MG; Senges J;
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S343-7. PubMed ID: 14704866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Summaries for patients. The effects of cholesterol and blood pressure treatments on severity of coronary artery disease.
    Ann Intern Med; 2006 Feb; 144(4):I22. PubMed ID: 16490905
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of the National Service Framework for coronary heart disease on treatment and outcome of patients with acute coronary syndromes.
    Graham JJ; Timmis A; Cooper J; Ramdany S; Deaner A; Ranjadayalan K; Knight C
    Heart; 2006 Mar; 92(3):301-6. PubMed ID: 15908481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of acute ST-segment elevation myocardial infarction. II. Beyond reperfusion.
    Glancy DL; Subramaniam PN; Pappas ND; Lewis RS
    J La State Med Soc; 2002; 154(5):235-40; quiz 240. PubMed ID: 12440750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction.
    Robinson CR; Martin JL; Zhang L; Canham RM; Abdullah SM; Cigarroa JE; Hillis LD; Murphy SA; McGuire DK; de Lemos JA; Keeley EC
    Am J Cardiol; 2006 Jan; 97(1):7-9. PubMed ID: 16377273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacological prevention of coronary relapses in Italian clinical practice: a literature review].
    Pedrinelli R; Ciccone M; Novo S; Catapano AL
    G Ital Cardiol (Rome); 2012 Nov; 13(11):734-40. PubMed ID: 23096582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
    Yahia DH; Pereg D; Lishner M; Elis A
    Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.